ConductScience.org, home

Paper40313573

Nanotechnology-based strategies for vaccine development: accelerating innovation and delivery.

Cheng M and 6 others. Biomater Transl, 2025. Cited by 14 papers, by iCite.

Cite this record

ConductScience Library. Nanotechnology-based strategies for vaccine development: accelerating innovation and delivery. Papers, record 40313573. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40313573

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Nanotechnology-based strategies for vaccine development: accelerating innovation and delivery.
PubMed
Journal
Biomater Transl
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
14
iCite
Relative citation ratio, by iCite
4.29, provisional
iCite
Revised in PubMed
2025-05-03
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cheng MMingrui
2Chai YYawei
3Rong GGuangyu
4Xin CChangchang
5Gu LLei
6Zhou XXujiao
7Hong JJiaxu

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References141

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
137573951Biosafety of mesoporous silica nanoparticles; towards clinical translation.Adv Drug Deliv Rev2023https://conductscience.org/library/papers/37573951PubMed
236602367The Respiratory Syncytial Virus (RSV) G Protein Enhances the Immune Responses to the RSV F Protein in an Enveloped Virus-Like Particle Vaccine Candidate.J Virol2023https://conductscience.org/library/papers/36602367PubMed
335683755Polymer Nanocomposites: Preparation, Characterisation and Applications.Nanomaterials (Basel)2022https://conductscience.org/library/papers/35683755PubMed
430172923Use of plant viruses and virus-like particles for the creation of novel vaccines.Adv Drug Deliv Rev2019https://conductscience.org/library/papers/30172923PubMed
519782542Biodegradable polymeric nanoparticles based drug delivery systems.Colloids Surf B Biointerfaces2010https://conductscience.org/library/papers/19782542PubMed
632807876Advances in nanomaterial vaccine strategies to address infectious diseases impacting global health.Nat Nanotechnol2021https://conductscience.org/library/papers/32807876PubMed
736149967Self-assembling peptide nanofiber HIV vaccine elicits robust vaccine-induced antibody functions and modulates Fc glycosylation.Sci Adv2022https://conductscience.org/library/papers/36149967PubMed
833277608Engineering precision nanoparticles for drug delivery.Nat Rev Drug Discov2021https://conductscience.org/library/papers/33277608PubMed
923067445Nanovaccinology: the next generation of vaccines meets 21st century materials science and engineering.Vaccine2012https://conductscience.org/library/papers/23067445PubMed
1033360074Polymeric nanoparticle vaccines to combat emerging and pandemic threats.Biomaterials2021https://conductscience.org/library/papers/33360074PubMed
1136423041Nanoparticle-Based Delivery Systems for Vaccines.Vaccines (Basel)2022https://conductscience.org/library/papers/36423041PubMed
1233824489Emerging concepts in the science of vaccine adjuvants.Nat Rev Drug Discov2021https://conductscience.org/library/papers/33824489PubMed
1338213286Novel Organoid Culture System for Improved Safety Assessment of Nanomaterials.Nano Lett2024https://conductscience.org/library/papers/38213286PubMed
1437705787Nanoparticle-based delivery systems as emerging therapy in retinoblastoma: recent advances, challenges and prospects.Nanoscale Adv2023https://conductscience.org/library/papers/37705787PubMed
1525557605Enhanced immune response to hepatitis B vaccination through immunization with a Pre-S1/Pre-S2/S vaccine.Med Microbiol Immunol2015https://conductscience.org/library/papers/25557605PubMed
1636713441Subunit vaccines for Acinetobacter baumannii.Front Immunol2022https://conductscience.org/library/papers/36713441PubMed
1711584378Evaluation of a new hepatitis B triple-antigen vaccine in inadequate responders to current vaccines.Hepatology2001https://conductscience.org/library/papers/11584378PubMed
1829801750Correlates of adjuvanticity: A review on adjuvants in licensed vaccines.Semin Immunol2018https://conductscience.org/library/papers/29801750PubMed
1922051890Vaccines for the twenty-first century society.Nat Rev Immunol2011https://conductscience.org/library/papers/22051890PubMed
2030733717Nanoparticle-Based Vaccines Against Respiratory Viruses.Front Immunol2019https://conductscience.org/library/papers/30733717PubMed

See all 141 referencesDownload CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.

PMIDTitleJournalYearIn PapersSource
42883287Evaluation of the Adjuvant Activity of Herniaria glabra Saponin-Based Nanoadjuvants.Molecules2026https://conductscience.org/library/papers/42883287PubMed
42760964Transforming therapeutics through biomaterials: A comprehensive insight into biomaterials' role in effective drug delivery and healthcare advancement.Biomater Transl2026https://conductscience.org/library/papers/42760964PubMed
42513179Nanoparticle Engineering in Modern Vaccinology: From Delivery Platforms to Immune-Programming Architectures.Molecules2026https://conductscience.org/library/papers/42513179PubMed
42405958Next-generation vaccine adjuvants: Integrating nanotechnology, systems immunology, and computational approaches for precision vaccinology.Hum Vaccin Immunother2026https://conductscience.org/library/papers/42405958PubMed
42188374Tumor-Targeted Delivery Therapy Based on PLGA Nanoparticles.J Funct Biomater2026https://conductscience.org/library/papers/42188374PubMed
41727253Modern plant stress adaptation: integrating defense, nanotechnology and genetics.3 Biotech2026https://conductscience.org/library/papers/41727253PubMed
41600930Engineering Enhanced Immunogenicity of Surface-Displayed Immunogens in a Killed Whole-Cell Genome-Reduced Bacterial Vaccine Platform Using Class I Viral Fusion Peptides.Vaccines (Basel)2025https://conductscience.org/library/papers/41600930PubMed
41012106Nanovaccines: Innovative Advances from Design Strategies to Clinical Translation.Vaccines (Basel)2025https://conductscience.org/library/papers/41012106PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40313573

GET https://conductscience.org/api/papers/v1/40313573/references?page=2